RXST Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $4.68

Market Cap (MRQ) $195M

P/E (TTM) -4.1

EPS (TTM) $-1.13

Revenue (TTM) $128M

ROE (TTM) -17.3%

52W Range $4–$13

RXST Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$134M

2020-12-31 → 2025-12-31

EPS$-0.95

2020-12-31 → 2025-12-31

Free Cash Flow$-19M

2022-12-31 → 2025-12-31

Net margin-36.8%

2022-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	RXST	5Y avg	Peer Median	Verdict
P/E (TTM)	-4.15Y avg ≈-19.3	≈-19.3	·	·
P/S (TTM)	1.55Y avg ≈9.2	≈9.2	1.8	Fair value
P/B (MRQ)	0.75Y avg ≈4.9	≈4.9	1.0	Undervalued
Price / FCF (TTM)	-7.25Y avg ≈-30.4	≈-30.4	·	·
Price / Cash Flow (TTM)	-8.65Y avg ≈-37.7	≈-37.7	·	·
Price / Tangible Book	0.75Y avg ≈4.4	≈4.4	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	RXST	5Y avg	Peer Median	Verdict
Gross Margin	76.6%5Y avg ≈62.8%	≈62.8%	56.1%	Top tier
Operating Margin (TTM)	-43.2%5Y avg ≈-61.9%	≈-61.9%	0.18%	Weak
EBITDA Margin (TTM)	-40.4%5Y avg ≈-57.5%	≈-57.5%	0.18%	Weak
Pretax Margin (TTM)	-36.7%5Y avg ≈-59.8%	≈-59.8%	-4.0%	Weak
Net Profit Margin (TTM)	-36.8%5Y avg ≈-59.8%	≈-59.8%	-4.1%	Weak
ROA (TTM)	-14.2%5Y avg ≈-22.9%	≈-22.9%	-14.0%	In line
ROE (TTM)	-17.3%5Y avg ≈-30.9%	≈-30.9%	-17.4%	Top tier
ROIC	-17.5%5Y avg ≈-33.1%	≈-33.1%	-17.5%	In line

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	RXST	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)	4.15Y avg ≈9.5	≈9.5	3.5	Strong liquidity
Quick Ratio (MRQ)	2.85Y avg ≈8.4	≈8.4	2.5	In line
Interest Coverage	-2536.45Y avg ≈-1079.9	≈-1079.9	-5.7	Low liquidity

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	RXST	5Y avg	Peer Median	Verdict
Revenue YoY	-3.9%5Y avg ≈61.2%	≈61.2%	·	·
Revenue CAGR 3Y	40.0%5Y avg ≈68.7%	≈68.7%	·	·
Revenue CAGR 5Y	55.7%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	RXST	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-0.955Y avg ≈$-1.81	≈$-1.81	·	·
Revenue / Share	$3.295Y avg ≈$2.81	≈$2.81	·	·
Cash Flow / Share	$-0.385Y avg ≈$-1.04	≈$-1.04	·	·
Cash / Share	$0.485Y avg ≈$0.40	≈$0.40	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	RXST	5Y avg	Peer Median	Verdict
Asset Turnover	0.45Y avg ≈0.5	≈0.5	0.7	Below avg
Inventory Turnover	1.25Y avg ≈2.0	≈2.0	2.1	Weak
Receivables Turnover	5.05Y avg ≈5.6	≈5.6	6.4	Weak
Revenue / Employee	≈$291.7K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 7.8%

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026		$-0.29	$-0.34	13.8%
March 31, 2026	May 12, 2026	$-0.38	$-0.29	-32.4%
Dec. 31, 2025		$-0.22	$-0.34	35.1%
Sept. 30, 2025		$-0.24	$-0.39	37.9%
June 30, 2025		$-0.29	$-0.25	-16.7%
March 31, 2025		$-0.20	$-0.22	9.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 16

Metric	2025	2024	2023	2022	2021	2020
Revenue	$134M	$140M	$89M	$49M	$23M	$15M
Cost of Revenue	$31M	$41M	$35M	$28M	$18M	$13M
Gross Profit	$103M	$99M	$54M	$21M	$5M	$2M
R&D Expense	$39M	$34M	$29M	$26M	$24M	$22M
SG&A Expense	$113M	$101M	$75M	$59M	$33M	$15M
Operating Expenses	$151M	$136M	$104M	$85M	$57M	$37M
Operating Income	$-48M	$-37M	$-50M	$-63M	$-53M	$-35M
Interest Expense	$19.0K	$21.0K	$3M	$5M	$4M	$510.0K
Pretax Income	$-39M	$-27M	$-49M	$-67M	$-49M	$28M
Income Tax	$66.0K	$50.0K	$20.0K	$9.0K	$8.0K	$57.0K
Net Income	$-39M	$-27M	$-49M	$-67M	$-49M	$28M
EPS (Basic)	$-0.95	$-0.71	$-1.41	$-2.41	$-3.57	$0.91
EPS (Diluted)	$-0.95	$-0.71	$-1.41	$-2.41	$-3.57	$0.15
Shares (Basic)	40,850,739	38,867,726	34,455,111	27,661,982	13,625,044	3,707,207
Shares (Diluted)	40,850,739	38,867,726	34,455,111	27,661,982	13,625,044	5,532,305
EBITDA	$-45M	$-33M	$-46M	$-59M	·	·

Balance Sheet 24

Metric	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$20M	$17M	$10M	$12M	$24M	$14M
Short-term Investments	$208M	$221M	$117M	$94M	$135M	$55M
Receivables	$23M	$30M	$20M	$11M	$5M	$3M
Inventory	$32M	$22M	$17M	$15M	$8M	$8M
Prepaid Expense	$4M	$5M	$4M	$3M	$4M	$1M
Current Assets	$287M	$294M	$168M	$135M	$176M	$82M
PP&E (Net)	$13M	$12M	$11M	$10M	$11M	$13M
PP&E (Gross)	$40M	$38M	$34M	$30M	$28M	$26M
Accum. Depreciation	$27M	$25M	$23M	$20M	$16M	$12M
Other Non-current Assets	$590.0K	$360.0K	$147.0K	$767.0K	$114.0K	$110.0K
Total Assets	$312M	$319M	$183M	$150M	$193M	$101M
Accounts Payable	$5M	$5M	$4M	$3M	$2M	$1M
Accrued Liabilities	$20M	$20M	$15M	$13M	$8M	$4M
Current Liabilities	$26M	$26M	$21M	$17M	$11M	$12M
Capital Leases	$10M	$11M	$1M	$3M	$4M	$5M
Total Liabilities	$36M	$37M	$22M	$60M	$54M	$45M
Long-term Debt	·	·	$0	$40M	$40M	$24M
Common Stock	$41.0K	$40.0K	$36.0K	$28.0K	$27.0K	$0
Paid-in Capital	$937M	$903M	$755M	$636M	$618M	$0
Retained Earnings	$-661M	$-622M	$-595M	$-546M	$-479M	$-431M
AOCI	$53.0K	$166.0K	$-5.0K	$-95.0K	$-20.0K	$-3.0K
Stockholders' Equity	$276M	$281M	$160M	$90M	$138M	$-431M
Liabilities + Equity	$312M	$319M	$183M	$150M	$193M	$101M
Shares Outstanding	41,242,005	40,428,220	36,139,513	28,268,389	27,366,746	1

Cash Flow 14

Metric	2025	2024	2023	2022	2021	2020
D&A	$3M	$4M	$4M	$4M	$4M	$4M
Stock-based Comp	$32M	$25M	$16M	$11M	$8M	$4M
Deferred Tax	$7M	$19M	$13M	$15M	$-13M	$-10M
Other Non-cash	$-18M	$-37M	$-16.0K	$8M	·	·
Operating Cash Flow	$-16M	$-17M	$-42M	$-59M	$-45M	$-35M
CapEx	$4M	$5M	$5M	$2M	$2M	$3M
Investing Cash Flow	$17M	$-99M	$-22M	$40M	$-82M	$16M
Stock Issued	$4M	$21M	$9M	$2M	$12M	·
Net Stock Activity	$4M	$21M	$9M	·	·	·
Financing Cash Flow	$2M	$123M	$62M	$6M	$137M	$25M
Net Change in Cash	$3M	$7M	$-2M	$-13M	$11M	$6M
Taxes Paid	$58.0K	$24.0K	$8.0K	$3.0K	$20.0K	$61.0K
Free Cash Flow	$-19M	$-22M	$-46M	$-61M	·	·
Levered FCF	$-19M	$-22M	$-50M	$-66M	·	·

Profitability 8

Metric	2025	2024	2023	2022	2021	2020
Gross Margin	76.6%	70.7%	60.4%	43.5%	·	·
Operating Margin	-35.8%	-26.3%	-56.2%	-129.2%	·	·
Net Margin	-29.0%	-19.6%	-54.6%	-136.2%	·	·
Pretax Margin	-28.9%	-19.6%	-54.5%	-136.2%	·	·
EBITDA Margin	-33.4%	-23.8%	-51.6%	-121.3%	·	·
ROA	-12.4%	-11.0%	-29.2%	-38.9%	·	·
ROE	-14.0%	-12.4%	-38.9%	-58.5%	·	·
ROIC	-17.5%	-13.1%	-31.2%	-70.4%	·	·

Liquidity & Solvency 3

Metric	2025	2024	2023	2022	2021	2020
Current Ratio	10.9	11.4	8.1	7.8	·	·
Quick Ratio	9.6	10.3	7.1	6.8	·	·
Interest Coverage	-2536.4	-1755.1	-15.1	-12.8	·	·

Efficiency 3

Metric	2025	2024	2023	2022	2021	2020
Asset Turnover	0.4	0.6	0.5	0.3	·	·
Inventory Turnover	1.2	2.1	2.2	2.4	·	·
Receivables Turnover	5.0	5.6	5.7	6.2	·	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020
Book Value / Share	$6.68	$6.96	$4.44	$3.18	·	·
Revenue / Share	$3.29	$3.60	$2.59	$1.77	·	·
Cash Flow / Share	$-0.38	$-0.44	$-1.21	$-2.13	·	·
Cash / Share	$0.48	$0.41	$0.27	$0.42	·	·
EPS (TTM)	$-0.95	$-0.71	$-1.41	$-2.41	$-3.57	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020
Revenue YoY	-3.9%	57.1%	81.8%	116.9%	53.9%	·
Revenue CAGR 3Y	40.0%	83.6%	82.4%	·	·	·
Revenue CAGR 5Y	55.7%	·	·	·	·	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020
Revenue TTM	$134M	$140M	$89M	$49M	$23M	·
Net Income TTM	$-39M	$-27M	$-49M	$-67M	$-49M	·
Market Cap	$430M	$1.39B	$1.46B	$358M	·	·
P/E	-11.0	-48.4	-28.6	-5.3	-3.2	·
P/S	3.2	9.9	16.4	7.3	·	·
P/B	1.6	4.9	9.1	4.0	·	·
P / Tangible Book	1.6	4.9	9.1	4.0	2.2	·
P / Cash Flow	-27.7	-82.0	-35.0	-6.1	·	·
P / FCF	-22.2	-62.1	-31.4	-5.8	·	·
Earnings Yield	-9.1%	-2.1%	-3.5%	-19.0%	-31.7%	·

Income Statement 16

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$34M	$31M	$33M	$30M	$34M	$38M	$40M	$35M	$35M	$30M	$29M	$22M	$21M	$17M	$16M	$13M
Cost of Revenue	$8M	$7M	$7M	$6M	$8M	$10M	$11M	$10M	$11M	$9M	$11M	$8M	$9M	$7M	$9M	$7M
Gross Profit	·	$23M	$25M	$24M	$25M	$28M	$29M	$25M	$24M	$21M	$18M	$14M	$12M	$10M	$7M	$5M
R&D Expense	$9M	$9M	$9M	$9M	$10M	$10M	$9M	$9M	$8M	$8M	$7M	$7M	$7M	$7M	$7M	$6M
SG&A Expense	$30M	$32M	$28M	$27M	$29M	$29M	$28M	$26M	$24M	$23M	$21M	$19M	$18M	$16M	$16M	$15M
Operating Expenses	$48M	$41M	$37M	$36M	$48M	$39M	$37M	$34M	$33M	$31M	$29M	$26M	$26M	$23M	$22M	$21M
Operating Income	$-14M	$-18M	$-11M	$-12M	$-14M	$-11M	$-9M	$-9M	$-8M	$-11M	$-11M	$-13M	$-14M	$-13M	$-15M	$-16M
Interest Expense	$3.0K	$3.0K	$4.0K	$4.0K	$5.0K	$6.0K	$4.0K	$5.0K	$6.0K	$6.0K	$3.0K	$230.0K	$2M	$2M	$1M	$1M
Pretax Income	$-12M	$-16M	$-9M	$-10M	$-12M	$-8M	$-6M	$-6M	$-6M	$-9M	$-9M	$-12M	$-14M	$-13M	$-16M	$-17M
Income Tax	$88.0K	$6.0K	$6.0K	$10.0K	$32.0K	$18.0K	$12.0K	$13.0K	$16.0K	$9.0K	$-18.0K	$12.0K	$26.0K	$0	$5.0K	$0
Net Income	$-12M	$-16M	$-9M	$-10M	$-12M	$-8M	$-6M	$-6M	$-6M	$-9M	$-9M	$-12M	$-14M	$-13M	$-16M	$-17M
EPS (Basic)	$-0.29	$-0.38	$-0.22	$-0.24	$-0.29	$-0.20	$-0.14	$-0.16	$-0.16	$-0.25	$-0.24	$-0.35	$-0.40	$-0.42	$-0.55	$-0.61
EPS (Diluted)	$-0.29	$-0.38	$-0.22	$-0.24	$-0.29	$-0.20	$-0.14	$-0.16	$-0.16	$-0.25	$-0.24	$-0.35	$-0.40	$-0.42	$-0.55	$-0.61
Shares (Basic)	41,490,889	41,306,110	·	40,965,219	40,743,786	40,509,646	·	39,788,621	38,455,955	36,843,087	·	35,662,397	34,498,265	31,637,097	·	27,665,842
Shares (Diluted)	41,490,889	41,306,110	·	40,965,219	40,743,786	40,509,646	·	39,788,621	38,455,955	36,843,087	·	35,662,397	34,498,265	31,637,097	·	27,665,842
EBITDA	$-14M	$-17M	·	$-12M	$-14M	$-10M	·	$-9M	$-8M	$-10M	·	$-13M	$-14M	$-12M	·	$-16M

Balance Sheet 24

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$13M	$18M	$20M	$30M	$40M	$28M	$17M	$17M	$24M	$33M	·	$10M	$9M	$11M	·	$9M
Short-term Investments	$195M	$200M	$208M	$198M	$187M	$201M	$221M	$220M	$209M	$93M	·	$122M	$138M	$143M	·	$104M
Receivables	$19M	$22M	$23M	$24M	$28M	$31M	$30M	$25M	$26M	$22M	·	$15M	$13M	$13M	·	$9M
Inventory	$37M	$35M	$32M	$29M	$25M	$24M	$22M	$22M	$19M	$19M	·	$19M	$18M	$18M	·	$15M
Prepaid Expense	$3M	$4M	$4M	$3M	$3M	$5M	$5M	$3M	$3M	$3M	·	$2M	$2M	$3M	·	$2M
Current Assets	$327M	$279M	$287M	$284M	$284M	$288M	$294M	$287M	$281M	$169M	·	$168M	$180M	$188M	·	$139M
PP&E (Net)	$14M	$13M	$13M	$13M	$13M	$13M	$12M	$12M	$12M	$12M	·	$10M	$11M	$10M	·	$11M
PP&E (Gross)	·	·	$40M	·	·	·	$38M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$27M	·	·	·	$25M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$1M	$1M	$590.0K	$536.0K	$542.0K	$401.0K	$360.0K	$213.0K	$303.0K	$226.0K	·	$137.0K	$348.0K	$746.0K	·	$782.0K
Total Assets	$353M	$304M	$312M	$309M	$309M	$313M	$319M	$310M	$305M	$183M	·	$182M	$195M	$203M	·	$156M
Accounts Payable	$6M	$7M	$5M	$3M	$3M	$7M	$5M	$5M	$5M	$5M	·	$4M	$4M	$4M	·	$4M
Accrued Liabilities	·	·	$20M	·	·	·	$20M	·	·	·	·	·	·	·	·	·
Current Liabilities	$80M	$27M	$26M	$22M	$20M	$23M	$26M	$23M	$20M	$18M	·	$19M	$17M	$15M	·	$16M
Capital Leases	$9M	$9M	$10M	$10M	$11M	$11M	$11M	$10M	$11M	$788.0K	·	$1M	$2M	$2M	·	$3M
Total Liabilities	$89M	$37M	$36M	$33M	$31M	$34M	$37M	$33M	$30M	$19M	·	$20M	$38M	$58M	·	$60M
Long-term Debt	·	·	·	·	·	·	·	·	·	·	·	$0	$20M	$40M	·	$40M
Common Stock	$41.0K	$41.0K	$41.0K	$41.0K	$41.0K	$41.0K	$40.0K	$40.0K	$40.0K	$37.0K	·	$36.0K	$35.0K	$34.0K	·	$28.0K
Paid-in Capital	$952M	$944M	$937M	$928M	$920M	$910M	$903M	$893M	$885M	$768M	·	$747M	$730M	$704M	·	$626M
Retained Earnings	$-689M	$-677M	$-661M	$-652M	$-642M	$-630M	$-622M	$-616M	$-610M	$-604M	·	$-585M	$-573M	$-559M	·	$-530M
AOCI	$-59.0K	$-67.0K	$53.0K	$60.0K	$-117.0K	$15.0K	$166.0K	$521.0K	$-118.0K	$-53.0K	·	$-60.0K	$-73.0K	$-9.0K	·	$-138.0K
Stockholders' Equity	$263M	$267M	$276M	$276M	$278M	$279M	$281M	$277M	$275M	$164M	·	$161M	$157M	$145M	·	$96M
Liabilities + Equity	$353M	$304M	$312M	$309M	$309M	$313M	$319M	$310M	$305M	$183M	·	$182M	$195M	$203M	·	$156M
Shares Outstanding	41,585,381	41,384,120	41,242,005	41,081,550	40,913,380	40,588,540	40,428,220	40,254,105	39,617,334	37,161,753	36,139,513	35,847,685	35,168,041	33,966,697	28,268,389	27,719,132

Cash Flow 13

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$999.0K	$834.0K	$851.0K	$854.0K	$785.0K	$776.0K	$515.0K	$1M	$812.0K	$1M	$1M	$1M	$989.0K	$955.0K	$918.0K	$941.0K
Stock-based Comp	$7M	$8M	$8M	$8M	$9M	$7M	$7M	$7M	$6M	$5M	$4M	$4M	$4M	$3M	$3M	$3M
Other Non-cash	·	$-4M	·	·	·	$-9M	·	·	·	$-6M	·	·	·	$-9M	·	·
Operating Cash Flow	$-10M	$-11M	$-1M	$-1M	$-4M	$-9M	$-4M	$650.0K	$-4M	$-9M	$-8M	$-8M	$-8M	$-18M	$-14M	$-15M
CapEx	$2M	$759.0K	$1M	$581.0K	$2M	$575.0K	$847.0K	$1M	$2M	$2M	$2M	$653.0K	$2M	$747.0K	$362.0K	$580.0K
Investing Cash Flow	$5M	$9M	$-10M	$-9M	$15M	$21M	$1M	$-9M	$-116M	$24M	$5M	$17M	$4M	$-48M	$10M	$560.0K
Stock Issued	$669.0K	$144.0K	$1M	$131.0K	$2M	$696.0K	$3M	$4M	$4M	$10M	$4M	$2M	$3M	$761.0K	$589.0K	$145.0K
Net Stock Activity	·	$144.0K	·	·	·	$696.0K	·	·	·	$10M	·	·	·	·	·	·
Financing Cash Flow	$662.0K	$-336.0K	$1M	$-530.0K	$2M	$-735.0K	$3M	$878.0K	$111M	$8M	$4M	$-8M	$891.0K	$65M	$6M	$-455.0K
Net Change in Cash	$-4M	$-2M	$-10M	$-11M	$12M	$11M	$24.0K	$-8M	$-8M	$23M	$-166.0K	$1M	$-2M	$-822.0K	$3M	$-15M
Taxes Paid	$144.0K	$0	$-12.0K	$0	$67.0K	$3.0K	$-2.0K	$2.0K	$24.0K	$0	$-4.0K	$0	$12.0K	$0	$0	$0
Free Cash Flow	·	$-12M	·	·	·	$-9M	·	·	·	$-11M	·	·	·	$-19M	·	·
Levered FCF	·	$-12M	·	·	·	$-9M	·	·	·	$-11M	·	·	·	$-20M	·	·

Profitability 8

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	·	76.1%	·	79.8%	74.9%	74.8%	·	71.4%	69.5%	70.1%	·	61.9%	57.7%	59.3%	·	42.5%
Operating Margin	-40.8%	-57.7%	·	-40.1%	-41.6%	-28.2%	·	-26.1%	-23.9%	-36.1%	·	-56.4%	-65.5%	-74.9%	·	-126.5%
Net Margin	-35.9%	-51.4%	·	-32.4%	-35.0%	-21.6%	·	-17.9%	-17.4%	-30.8%	·	-55.9%	-66.3%	-75.5%	·	-133.3%
Pretax Margin	-35.6%	-51.4%	·	-32.3%	-34.9%	-21.6%	·	-17.9%	-17.4%	-30.8%	·	-55.9%	-66.2%	-75.5%	·	-133.3%
EBITDA Margin	-40.8%	-55.0%	·	-40.1%	-41.6%	-26.1%	·	-26.1%	-23.9%	-32.4%	·	-56.4%	-65.5%	-69.4%	·	-126.5%
ROA	-3.7%	-5.1%	·	-3.2%	-3.8%	-3.3%	·	-2.6%	-2.4%	-4.7%	·	-7.4%	-7.6%	-7.0%	·	-9.4%
ROE	-4.5%	-5.8%	·	-3.5%	-4.3%	-3.7%	·	-2.9%	-2.8%	-5.9%	·	-9.7%	-10.3%	-9.8%	·	-13.6%
ROIC	-5.3%	-6.7%	·	-4.4%	-5.1%	-3.8%	·	-3.3%	-3.0%	-6.5%	·	-7.8%	-8.7%	-9.0%	·	-16.6%

Liquidity & Solvency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.1	10.2	·	12.7	13.9	12.7	·	12.7	14.3	9.2	·	8.9	10.9	12.6	·	8.5
Quick Ratio	2.8	8.8	·	11.3	12.5	11.4	·	11.6	13.2	8.0	·	7.8	9.7	11.2	·	7.4
Interest Coverage	-4590.0	-5943.0	·	-3044.5	-2800.6	-1779.0	·	-1845.2	-1388.8	-1778.3	·	-54.4	-8.7	-8.7	·	-12.3

Efficiency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.2	·	0.1	0.1	0.2	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.3	0.3	·	0.2	0.4	0.5	·	0.5	0.6	0.5	·	0.5	0.6	0.5	·	0.6
Receivables Turnover	1.4	1.2	·	1.2	1.3	1.4	·	1.7	1.8	1.7	·	1.8	2.1	1.9	·	1.9

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$6.33	$6.46	·	$6.72	$6.80	$6.88	·	$6.89	$6.95	$4.41	·	$4.50	$4.47	$4.27	·	$3.46
Revenue / Share	$0.81	$0.75	·	$0.74	$0.83	$0.94	·	$0.89	$0.91	$0.80	·	$0.62	$0.60	$0.55	·	$0.46
Cash Flow / Share	·	$-0.26	·	·	·	$-0.22	·	·	·	$-0.25	·	·	·	$-0.56	·	·
Cash / Share	$0.32	$0.42	·	$0.72	$0.99	$0.69	·	$0.42	$0.62	$0.88	·	$0.28	$0.25	$0.32	·	$0.32
EPS (TTM)	$-1.13	$-1.13	·	$-0.87	$-0.79	$-0.66	·	$-0.81	$-1.00	$-1.24	·	$-1.72	$-1.98	$-2.19	·	$-1.77

Valuation (TTM) 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$128M	$127M	·	$142M	$147M	$148M	·	$128M	$115M	$101M	·	$77M	$67M	$58M	·	$41M
Net Income TTM	$-47M	$-47M	·	$-36M	$-32M	$-27M	·	$-31M	$-37M	$-44M	·	$-55M	$-59M	$-62M	·	$-67M
Market Cap	$200M	$255M	·	$369M	$532M	$1.02B	·	$1.99B	$2.38B	$1.92B	·	$1000M	$1.01B	$567M	·	$333M
P/E	-4.3	-5.5	·	-10.3	-16.5	-38.3	·	-61.0	-60.2	-41.6	·	-16.2	-14.5	-7.6	·	-6.8
P/S	1.6	2.0	·	2.6	3.6	6.9	·	15.5	20.7	19.0	·	13.1	15.1	9.8	·	8.0
P/B	0.8	1.0	·	1.3	1.9	3.7	·	7.2	8.7	11.7	·	6.2	6.4	3.9	·	3.5
P / Tangible Book	0.8	1.0	·	1.3	1.9	3.7	·	7.2	8.7	11.7	·	6.2	6.4	3.9	·	3.5
P / Cash Flow	·	-23.4	·	·	·	-116.0	·	·	·	-205.9	·	·	·	-31.9	·	·
Earnings Yield	-23.4%	-18.3%	·	-9.7%	-6.1%	-2.6%	·	-1.6%	-1.7%	-2.4%	·	-6.2%	-6.9%	-13.1%	·	-14.8%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$134M	$140M	$89M	$49M	$23M
Gross Margin %	76.6%	70.7%	60.4%	43.5%	·
Operating Margin %	-35.8%	-26.3%	-56.2%	-129.2%	·
Net Income	$-39M	$-27M	$-49M	$-67M	$-49M
Diluted EPS	$-0.95	$-0.71	$-1.41	$-2.41	$-3.57

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Current Ratio	10.9	11.4	8.1	7.8	·
Quick Ratio	9.6	10.3	7.1	6.8	·

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-19M	$-22M	$-46M	$-61M	·

Institutional owners (13F) 165 filers · $226.1M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 165

Value held $226.1M

New positions 27

Exited positions 36

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
27 (-8 vs prior Q)	36 (+7 vs prior Q)	70 (+8 vs prior Q)	36 (-18 vs prior Q)	+3.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
BlackRock, Inc.	$27,909,765	5,790,408	12.35%	Shares
VANGUARD GROUP INC	$23,231,797	2,229,539	10.28%	Shares
MILLENNIUM MANAGEMENT LLC	$14,605,983	3,030,287	6.46%	Shares
No Street GP LP	$9,905,100	2,055,000	4.38%	Shares
NOMURA HOLDINGS INC	$9,640,289	2,000,060	4.26%	Shares
D. E. Shaw & Co., Inc.	$9,568,737	1,985,215	4.23%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$8,076,305	1,675,582	3.57%	Shares
TWO SIGMA ADVISERS, LP	$7,628,482	732,100	3.37%	Shares
AQR CAPITAL MANAGEMENT LLC	$7,393,041	1,533,826	3.27%	Shares
FEDERATED HERMES, INC.	$5,789,760	1,201,195	2.56%	Shares
TWO SIGMA INVESTMENTS, LP	$5,528,771	1,147,048	2.45%	Shares
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	$5,453,348	1,131,400	2.41%	Shares
UBS Group AG	$4,897,438	1,016,066	2.17%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$4,813,103	998,569	2.13%	Shares
MARSHALL WACE, LLP	$4,800,316	995,916	2.12%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$4,748,847	984,978	2.10%	Shares
STATE STREET CORP	$4,104,288	851,512	1.82%	Shares
Point72 Asset Management, L.P.	$3,751,175	778,252	1.66%	Shares
Grandeur Peak Global Advisors, LLC	$3,482,161	722,440	1.54%	Shares
Schonfeld Strategic Advisors LLC	$3,380,828	701,417	1.50%	Shares
CITADEL ADVISORS LLC	$3,377,548	700,736	1.49%	Shares
Trexquant Investment LP	$2,930,247	607,935	1.30%	Shares
GOLDMAN SACHS GROUP INC	$2,632,463	546,154	1.16%	Shares
DEUTSCHE BANK AG\	$2,603,803	540,208	1.15%	Shares
NORGES BANK	$2,410,000	500,000	1.07%	Shares
Qube Research & Technologies Ltd	$2,369,271	491,550	1.05%	Shares
BANK OF AMERICA CORP /DE/	$2,339,136	485,298	1.03%	Shares
ALGERT GLOBAL LLC	$1,990,752	413,019	0.88%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$1,854,885	384,831	0.82%	Shares
Walleye Capital LLC	$1,725,734	358,036	0.76%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1,507,609	312,782	0.67%	Shares
MORGAN STANLEY	$1,502,709	311,765	0.66%	Shares
NORTHERN TRUST CORP	$1,498,986	310,993	0.66%	Shares
Vitruvian Partners LLP	$1,344,129	278,865	0.59%	Shares
Cubist Systematic Strategies, LLC	$1,316,190	146,406	0.58%	Shares
TOCQUEVILLE ASSET MANAGEMENT L.P.	$1,277,300	265,000	0.57%	Shares
Jump Financial, LLC	$1,184,756	245,800	0.52%	Shares
VANGUARD FIDUCIARY TRUST CO	$1,169,626	242,661	0.52%	Shares
Russell Investments Group, Ltd.	$1,111,914	230,687	0.49%	Shares
BROWN CAPITAL MANAGEMENT LLC	$1,042,566	216,300	0.46%	Shares
Y-Intercept (Hong Kong) Ltd	$886,600	183,942	0.39%	Shares
CANADA PENSION PLAN INVESTMENT BOARD	$873,866	181,300	0.39%	Shares
BNP PARIBAS FINANCIAL MARKETS	$810,107	168,072	0.36%	Shares
Nebula Research & Development LLC	$780,624	60,048	0.35%	Shares
Carnegie Lake Advisors LLC	$745,871	154,745	0.33%	Shares
MOORE CAPITAL MANAGEMENT, LP	$730,230	151,500	0.32%	Shares
IEQ CAPITAL, LLC	$701,686	145,578	0.31%	Shares
RENAISSANCE TECHNOLOGIES LLC	$678,140	140,693	0.30%	Shares
TUDOR INVESTMENT CORP ET AL	$634,968	131,736	0.28%	Shares
Nuveen, LLC	$606,250	125,778	0.27%	Shares

Show all 165 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 filings	Aug. 18, 2023	·	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 20 insiders · 7 officers · 13 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Aziz Mottiwala	President and CEO	July 24, 2026 A	·	0	$0
Mark Wilterding	Chief Financial Officer	Sept. 5, 2026 A	25,049	1	$-54,044
Shelley B Thunen	Co-President and Chief Financial Officer	April 14, 2025 M	38,354	0	$0
Ilya Goldshleger	Chief Operating Officer	Sept. 5, 2026 A	81,509	1	$-14,205
Eric Weinberg	Chief Business Development Officer	Sept. 15, 2026 M	235,516	1	$-14,205
Ronald M Kurtz MD	Chief Medical Officer	Sept. 5, 2026 A	71,775	1	$-35,496
Scott Gaines	Chief Customer Officer	Feb. 28, 2026 M	14,848	0	$0
Tamara Fountain	Director	June 17, 2026 A	72,582	0	$0
Jesse Anderson Corley	Director	June 17, 2026 A	86,227	0	$0
Robert Keith Warner	Director	June 17, 2026 A	78,076	0	$0
Shweta Maniar	Director	June 17, 2026 A	55,172	0	$0
Julie Andrews	Director	June 17, 2026 A	78,076	0	$0
Bakker Juliet Tammenoms	Director	June 17, 2026 A	85,183	0	$0
Raymond W Cohen	Director	June 17, 2026 A	66,532	0	$0
William J Link PHD	Director	June 17, 2026 A	74,892	0	$0
PALMISANO ROBERT J	Director	June 17, 2026 A	78,076	0	$0
Daniel Mark Schwartz	Director	Aug. 3, 2021 C	407,647	0	$0
Richard M. Wolfen	Director	Aug. 3, 2021 C	1,762,074	0	$0
Bruce C Robertson	Director	Aug. 3, 2021 C	1,385,037	0	$0
RxSight I, LLC	10% owner	Aug. 3, 2021 C	2,016,778	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 13 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IWC · iShares Trust	0.06%	135,173 SH	Sept. 11, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.01%	64,757 SH	Oct. 2, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.01%	229,196 SH	Aug. 19, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.01%	34,670 SH	Aug. 19, 2026	Daily
IWM · iShares Trust	0.01%	1,009,611 SH	Sept. 11, 2026	Daily
RSSL · Global X Funds	0.01%	19,058 NS	July 31, 2026	N-PORT
ITOT · iShares Trust	0.00%	47,040 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.00%	8,390 SH	Sept. 11, 2026	Daily
VXF · VANGUARD INDEX FUNDS	0.00%	409,293 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	1,227,155 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	2,919 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.00%	118,046 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	359,153 SH	Sept. 11, 2026	Daily

RXST Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 15 analysts HOLD

Median target $6.65 +42.1%

0 0.0% Strong Buy

1 6.7% Buy

9 60.0% Hold

3 20.0% Sell

2 13.3% Strong Sell

12-Month Price Target

8 analysts · 2026-09-30

Mean target $7.57 +61.7%

← Below all targets Current price $4.68

Low$5.50 Mean$7.57 High$11.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
RXST	$430M	-11.0	-3.9%	-29.0%	-14.0%	76.6%
SMTI	$209M	-5.4	19.0%	-36.4%	-165.7%	92.7%
EMBC	$825M	8.7	-3.8%	8.8%	-13.8%	62.6%
OSUR	$170M	-2.6	-38.1%	-59.8%	-19.1%	41.9%
UTMD	$178M	16.1	-5.8%	29.3%	9.5%	57.1%
SKYA	·	·	·	·	·	·
TELA	$53M	-1.4	15.8%	-48.4%	-501.1%	67.7%
RMTI	$33M	-5.5	-31.8%	-7.7%	-15.8%	16.9%
NSPR	$77M	-2.3	28.1%	-543.3%	-129.3%	29.5%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

RXST RxSight, Inc. - Common Stock